Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content
OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content
Specialty
View More
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
eNewsletter
Print Subscription
Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content
Specialty
See All >
Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer
Kathleen N. Moore, MD, University of Oklahoma
home
Articles
Future of Advanced Endometrial Cancer
January 4th 2021
Novel Targets for Advanced Endometrial Cancer
January 4th 2021
Endometrial Cancer: Chemo-Free Regimens on the Horizon
January 4th 2021
Emerging Agents: Treatment of Endometrial Cancer
January 4th 2021
Sequencing for Advanced Endometrial Cancer
January 4th 2021
Recurrent Endometrial Cancer: Safety of Combination Therapy
January 4th 2021
Combination Therapy for Recurrent Endometrial Cancer
January 4th 2021
Emerging ICI Therapy for Advanced Endometrial Cancer
January 4th 2021
Immune Checkpoint Inhibitors in Advanced Endometrial Cancer
January 4th 2021
GOG-258 and PORTEC-3 Studies in Endometrial Cancer
January 4th 2021
GOG-249 Study in Early-Stage Endometrial Cancer
January 4th 2021
GOG 0209 Study in Advanced Endometrial Cancer
January 4th 2021
Role of Biomarker Testing in Endometrial Cancer
January 4th 2021
Risk Classification of Endometrial Cancer
January 4th 2021
Overview of Endometrial Cancer
January 4th 2021
Systemic Management of Ovarian Cancer: Closing Thoughts
May 27th 2020
Novel Combination Strategies in Recurrent Ovarian Cancer
May 27th 2020
Recurrent Ovarian Cancer: Novel Agents Under Investigation
May 27th 2020
Bevacizumab’s Role in Recurrent Ovarian Cancer
May 27th 2020
Recurrent Ovarian Cancer: Choosing a PARP Inhibitor
May 27th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE